Cholesterol metabolism and colorectal cancer: the plot thickens

This publication has 16 references indexed in Scilit:

• Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment‐resistant melanoma, colorectal, and lung cancer
  Pigment Cell & Melanoma Research, 2018
• Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis
  Cell Stem Cell, 2018
• YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration
  Cell Stem Cell, 2018
• Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
  European Journal of Cancer, 2017
• Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
  Annals of Oncology, 2014
• A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention
  Cancer Cell, 2013
• Cholesterol metabolism and colorectal cancers
  Current Opinion in Pharmacology, 2012
• V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a
  EMBO Molecular Medicine, 2010
• The Effect of Statins in Colorectal Cancer Is Mediated Through the Bone Morphogenetic Protein Pathway
  Gastroenterology, 2007
• HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
  Leukemia, 2002